{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:19:02Z","timestamp":1790864342114,"version":"4.1.0"},"reference-count":19,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1779,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1111\/j.1365-2362.2010.02401.x","type":"journal-article","created":{"date-parts":[[2010,10,18]],"date-time":"2010-10-18T12:40:31Z","timestamp":1287405631000},"page":"189-194","source":"Crossref","is-referenced-by-count":13,"title":["Assessment of serum sodium to urinary sodium divided by (serum potassium)\u00b2 to urinary potassium as a screening tool for primary aldosteronism"],"prefix":"10.1111","volume":"41","author":[{"given":"Olivier","family":"Steichen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Fran\u00e7ois","family":"Plouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,10,18]]},"reference":[{"key":"10.1111\/j.1365-2362.2010.02401.x-BIB1|cit1","first-page":"220","article-title":"Aldosterone-to-renin ratio as a screening test for primary aldosteronism - the Dutch ARRAT Study","volume":"66","author":"Jansen","year":"2008","journal-title":"Neth J Med"},{"key":"10.1111\/j.1365-2362.2010.02401.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline","volume":"93","author":"Funder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1365-2362.2010.02401.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/00004872-200405000-00001","article-title":"The current epidemic of primary aldosteronism: causes and consequences","volume":"22","author":"Kaplan","year":"2004","journal-title":"J Hypertens"},{"key":"10.1111\/j.1365-2362.2010.02401.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1530\/EJE-09-0869","article-title":"A detour guide to the Endocrine Society Clinical Practice Guideline on case detection, diagnosis and treatment of patients with primary aldosteronism","volume":"162","author":"Arlt","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1111\/j.1365-2362.2010.02401.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0398-0499(06)76513-1","article-title":"Prise en charge des patients adultes atteints d\u2019hypertension art\u00e9rielle essentielle - Actualisation 2005","volume":"31","author":"Haute Autorit\u00e9","year":"2006","journal-title":"J Mal Vasc"},{"key":"10.1111\/j.1365-2362.2010.02401.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"10.1111\/j.1365-2362.2010.02401.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/08037050701461084","article-title":"2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"16","author":"Mancia","year":"2007","journal-title":"Blood Press"},{"key":"10.1111\/j.1365-2362.2010.02401.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents","volume":"89","author":"Mulatero","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1365-2362.2010.02401.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1365-2362.2010.02401.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1097\/00004872-200311000-00025","article-title":"High rate of detection of primary aldosteronism, including surgically treatable forms, after \u2018non-selective\u2019 screening of hypertensive patients","volume":"21","author":"Stowasser","year":"2003","journal-title":"J Hypertens"},{"key":"10.1111\/j.1365-2362.2010.02401.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2362.2008.02060.x","article-title":"The serum sodium to urinary sodium to (serum potassium)\u00b2 to urinary potassium (SUSPPUP) ratio in patients with primary aldosteronism","volume":"39","author":"Willenberg","year":"2009","journal-title":"Eur J Clin Invest"},{"key":"10.1111\/j.1365-2362.2010.02401.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/hr.2010.76","article-title":"Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism","volume":"33","author":"Balas","year":"2010","journal-title":"Hypertens Res"},{"key":"10.1111\/j.1365-2362.2010.02401.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1161\/HYPERTENSIONAHA.108.122002","article-title":"Fasting plasma glucose and serum lipids in patients with primary aldosteronism: a controlled cross-sectional study","volume":"53","author":"Matrozova","year":"2009","journal-title":"Hypertension"},{"key":"10.1111\/j.1365-2362.2010.02401.x-BIB14|cit14","first-page":"327","article-title":"Integrating management and expertise in a computerised system for hypertensive patients","volume":"2","author":"Devries","year":"1987","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1365-2362.2010.02401.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"300","DOI":"10.7326\/0003-4819-125-4-199608150-00008","article-title":"The urinary metanephrine-to-creatinine ratio for the diagnosis of pheochromocytoma","volume":"125","author":"Heron","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1365-2362.2010.02401.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1148\/radiology.148.3.6878708","article-title":"A method of comparing the areas under receiver operating characteristic curves derived from the same cases","volume":"148","author":"Hanley","year":"1983","journal-title":"Radiology"},{"key":"10.1111\/j.1365-2362.2010.02401.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1373\/49.1.7","article-title":"The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration","volume":"49","author":"Bossuyt","year":"2003","journal-title":"Clin Chem"},{"key":"10.1111\/j.1365-2362.2010.02401.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2362.2009.02234.x","article-title":"A catalogue of reporting guidelines for health research","volume":"40","author":"Simera","year":"2010","journal-title":"Eur J Clin Invest"},{"key":"10.1111\/j.1365-2362.2010.02401.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1161\/HYPERTENSIONAHA.107.104448","article-title":"About an epidemic of primary aldosteronism","volume":"51","author":"Plouin","year":"2008","journal-title":"Hypertension"}],"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2362.2010.02401.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2362.2010.02401.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T00:30:26Z","timestamp":1625358626000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2362.2010.02401.x"}},"subtitle":["THE SUSPPUP RATIO TO SCREEN FOR PRIMARY ALDOSTERONISM"],"short-title":[],"issued":{"date-parts":[[2010,10,18]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2362.2010.02401.x","relation":{},"ISSN":["0014-2972"],"issn-type":[{"value":"0014-2972","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10,18]]}}}